PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshemolytic anemia
MeSH D000743 - hemolytic anemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000740:Anemia
$
Success rate
D000743: 
Hemolytic anemia
D000744:Hemolytic anemia autoimmune
$
Success rate
D000745:Hemolytic anemia congenital
0 Companies
0 Drugs
Success rate
D005236:Favism
0 Companies
0 Drugs
Success rate
D006457:Paroxysmal hemoglobinuria
$
Success rate
D006463:Hemolytic-uremic syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPrednisolone Prednisolone  1999-05-28   
Prednisolone Prelone  1986-02-04   
Taro PharmaceuticalPrednisolone Flo-pred 2028-10-11 2008-01-17   
Rising PharmaceuticalsPrednisolone Prednisolone  1982-01-01   
Lupin ResearchPrednisolone Prednisolone  2024-08-02   
Genus LifesciencesPrednisolone, Sulfacetamide Sulfacetamide Prednisolone  1993-05-27   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
40%
2/5
Phase 2
11%
1/9
Phase 3
89%
8/9
Approved: 7Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use